The Enterprise Value as of December 2025 (TTM) for Maze Therapeutics, Inc. (MAZE) is 1.76B

According to Maze Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.76B. This represents a change of 263.25% compared to the average of 483.75M of the last 4 quarters.

Maze Therapeutics, Inc. (MAZE) Historical Enterprise Value (quarterly & annually)

How has MAZE Enterprise Value performed in the past?

The mean historical Enterprise Value of Maze Therapeutics, Inc. over the last ten years is 625.82M. The current 1.76B Enterprise Value has changed 27.98% with respect to the historical average. Over the past ten years (40 quarters), MAZE's Enterprise Value was at its highest in in the September 2025 quarter at 894.47M. The Enterprise Value was at its lowest in in the September 2023 quarter at 0.

Maze Therapeutics, Inc. (MAZE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Maze Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maze Therapeutics, Inc. (MAZE) Average Enterprise Value

How has MAZE Enterprise Value performed in the past?

The current Enterprise Value of Maze Therapeutics, Inc. (MAZE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Maze Therapeutics, Inc. (MAZE) Enterprise Value vs. Peers

How is MAZE’s Enterprise Value compared to its peers?

Maze Therapeutics, Inc.’s Enterprise Value is greater than Zymeworks Inc. (-43935349065.00), greater than Ardelyx, Inc. (1.58B), greater than Pharvaris N.V. (1.34B), less than BioCryst Pharmaceuticals, Inc. (2.30B), greater than Immunome, Inc. (1.70B), less than Spyre Therapeutics, Inc. (1.96B), less than Sionna Therapeutics, Inc. (1.79B), greater than Intellia Therapeutics, Inc. (925.20M), greater than Wave Life Sciences Ltd. (1.07B), greater than Trevi Therapeutics, Inc. (1.67B),

Build a custom stock screener for Maze Therapeutics, Inc. (MAZE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Maze Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Maze Therapeutics, Inc. (MAZE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Maze Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.